Table 5.
Multivariable model 1a (276 patients, 109 events) |
Multivariable model 2b (277 patients, 109 events) |
||||
---|---|---|---|---|---|
OR (95 % CI) | P-value | OR (95 % CI) | P-value | Pointsc | |
Radiological PI score (ref. Up to 6) | 0.006* | 0.004* | |||
7−10 | 1.12 (0.46−2.75) | 0.798 | 1.10 (0.46−2.63) | 0.836 | 4 |
11−14 | 1.71 (0.67−4.39) | 0.262 | 1.76 (0.72−4.27) | 0.213 | 26 |
≥15 | 5.71 (1.93−16.92) | 0.002* | 5.86 (2.06−16.65) | 0.001* | 80 |
Radiological PC score (ref. A) | 0.485 | Not included | |||
B | 1.50 (0.70−3.21) | 0.292 | |||
C, D, E | 1.56 (0.66−3.67) | 0.308 | |||
Age (ref. < 65 years) | 0.001* | <0.001* | |||
65−80 | 3.09 (1.43−6.67) | 0.004* | 3.04 (1.44−6.42) | 0.004* | 50 |
>80 years | 5.71 (2.12−15.35) | 0.001* | 9.07 (3.65−22.55) | <0.001* | 100 |
Male sex (ref. Female) | 2.72 (1.34−5.50) | 0.006* | 2.66 (1.34−5.31) | 0.005* | 44 |
Arterial hypertension | 1.54 (0.81−2.95) | 0.189 | 1.58 (0.83−2.98) | 0.163 | 21 |
SaO2 (ref. 95 %–100 %) | 0.025* | 0.024* | |||
85 %-94 % | 1.79 (0.70−4.57) | 0.221 | 1.60 (0.64−4.03) | 0.315 | 21 |
<85 % | 4.32 (1.42−13.15) | 0.010* | 3.95 (1.34−11.66) | 0.013* | 62 |
WBC >10000/mmc (ref. ≤ 10000/mmc) | 2.26 (1.04−4.89) | 0.039* | 2.07 (0.98−4.36) | 0.055 | 33 |
AST ≥50 U/L (ref. < 50 U/L) | 2.15 (1.10−4.21) | 0.025* | 2.10 (1.10−4.01) | 0.025* | 34 |
SIMIT therapy | 0.41 (0.19−0.89) | 0.024* | Not included |
Abbreviations: SIMIT, Italian Infectious Disease Society; OR, odds ratio; 95 % CI, 95 % confidence interval; PI score, pulmonary involvement score; PC score, pulmonary consolidation score; SaO2, arterial saturation of oxygen; WBC, white blood cell; AST, aspartate aminotransferase.
Variables not selected with stepwise procedure: Ischemic heart disease, oncological pathology, lymphocytes, CRP.
Variables not selected with a stepwise procedure: ischemic heart disease, oncological pathology, lymphocytes, CRP, radiological score PC.
Points associated with the reference category were 0.
Statistically significant.